NCT00828776View on ClinicalTrials.gov

Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Chronic Renal Failure
Interventions
BIOLOGICAL

Heparin sodic - Cristália

5000UI/mL

BIOLOGICAL

heparin - Liquemine (Roche)

5000UI/mL

Trial Locations (1)

13270000

Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos

All Listed Sponsors
lead

Azidus Brasil

INDUSTRY

NCT00828776 - Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure | Biotech Hunter | Biotech Hunter